<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Skoblenick Lab</title><link>https://skobrain.org/</link><description>Recent content on Skoblenick Lab</description><generator>Hugo -- 0.146.0</generator><language>en-us</language><lastBuildDate>Tue, 26 Aug 2025 00:00:00 +0000</lastBuildDate><atom:link href="https://skobrain.org/index.xml" rel="self" type="application/rss+xml"/><item><title>mTBI Biomarker Resources</title><link>https://skobrain.org/mtbi/</link><pubDate>Tue, 26 Aug 2025 00:00:00 +0000</pubDate><guid>https://skobrain.org/mtbi/</guid><description>&lt;h2 id="whats-on-this-page">&lt;strong>Whatâ€™s on this page:&lt;/strong>&lt;/h2>
&lt;p>Access to the validation papers behind the mTBI biomarker and clinical resources for the ED physician.&lt;/p>
&lt;hr>
&lt;h2 id="validation-papers">Validation Papers&lt;/h2>
&lt;ul>
&lt;li>&lt;strong>Papa et al. (2016)&lt;/strong> â€” 584 patients. GFAP performed consistently in detecting MMTBI, CT lesions, and neurosurgical intervention across 7 days. UCH-L1 performed best in the early postinjury period. &lt;a href="https://skobrain.org/files/mtbi/Papa-2016.pdf">PDF&lt;/a> (&lt;em>JAMA Neurology&lt;/em>)&lt;/li>
&lt;li>&lt;strong>Yue et al. (2019)&lt;/strong> â€” 450 patients. Measuring blood GFAP with a point-of-care test within 24 hours of injury can help detect TBI and flag patients who need imaging or follow-up. &lt;a href="https://skobrain.org/files/mtbi/Yue-2019.pdf">PDF&lt;/a> (&lt;em>Lancet Neurology&lt;/em>)&lt;/li>
&lt;li>&lt;strong>Bazarian et al. (2021)&lt;/strong> â€” 1936 patients. In over 1,900 patients with mild TBI, the biomarker showed very high sensitivity (~96%) and negative predictive value (&amp;gt;99%) for detecting CT-positive brain injuries. &lt;a href="https://skobrain.org/files/mtbi/Bazarian-2021.pdf">PDF&lt;/a> (&lt;em>Academic Emergency Medicine&lt;/em>)&lt;/li>
&lt;li>&lt;strong>Menditto et al. (2024)&lt;/strong> â€” 234 patients, mean age 81 years old. Patients were included even if taking a DOAC or warfarin. GFAP had a 100% negative predictive value. &lt;a href="https://skobrain.org/files/mtbi/Menditto-2024.pdf">PDF&lt;/a> (&lt;em>Clin Chem Lab Med&lt;/em>)&lt;/li>
&lt;li>&lt;strong>Welch et al. (2025)&lt;/strong> â€” 1899 patients, age 18-98 years old with head injury and GCS 9-15 in ED. Sensitivity 96.7%, negative predictive value 99.4%. &lt;a href="https://skobrain.org/files/mtbi/Welch-2025.pdf">PDF&lt;/a> (&lt;em>American Journal of Emergency Medicine&lt;/em>)&lt;/li>
&lt;/ul>
&lt;h2 id="clinical-practice">Clinical Practice&lt;/h2>
&lt;p>&lt;strong>Suggested algorithm for the use of mTBI in the emergency department:&lt;/strong>
&lt;figure>
&lt;img loading="lazy" src="https://skobrain.org/files/mtbi/mtbi-algorithm.png"
alt="mTBI algorithm"/> &lt;figcaption>
&lt;p>Suggested algorithm for the use of mTBI in the emergency department&lt;/p></description></item><item><title>Contact</title><link>https://skobrain.org/contact/</link><pubDate>Tue, 05 Aug 2025 00:00:00 +0000</pubDate><guid>https://skobrain.org/contact/</guid><description>&lt;p>If you&amp;rsquo;re interested in collaborating or learning more about our research, please get in touch:&lt;/p>
&lt;p>&lt;strong>Dr. Kevin Skoblenick&lt;/strong>&lt;br>
Emergency Physician &amp;amp; Clinician-Scientist&lt;br>
University of Alberta&lt;/p>
&lt;p>ðŸ“§ &lt;a href="mailto:skobleni@ualberta.ca">skobleni@ualberta.ca&lt;/a>&lt;br>
ðŸ”— &lt;a href="https://orcid.org/0000-0003-4404-0234">ORCID&lt;/a>&lt;br>
ðŸ”Ž &lt;a href="https://scholar.google.com/scholar?hl=en&amp;amp;q=Kevin+Skoblenick">Google Scholar&lt;/a>&lt;/p></description></item></channel></rss>